US$ 23.50
evaluate the pharmaceuticals company saxenda on glp-1 efficacy / effectiveness Oral Treatment of Obesity by and Its Analogs New pharmacological treatments for obesity:
Description
Sohn EH, et al

330, no

[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Bodhale DW, Nisar A, Afzulpurkar N

So we think of it really as a disease in which we have a treatment for it that we can hopefully put the individual control it and hopefully put them in remission but currently it only works if you take the medication

DIABETES, VOL 51, SUPP 3, DEC 2002
In a study analyzing the risk of hypoglycemia after glucose-lowering treatment utilizing the Japanese Adverse Drug Event Report (JADER) database, lixisenatide also showed higher ROR and IC values than the other two GLP-1RAs, exenatide and liraglutide (35)
